VAERS reports by lot

Seqirus / CSL Flu lot R52206: VAERS reports

23 VAERS reports list lot R52206 as a Seqirus / CSL Flu vaccine, received between 2013-08-14 and 2015-07-27. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
30%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1522%
Musculoskeletal1421%
Neurological1116%
Dermatological (non-injection-site)710%
General / Systemic (non-local)69%
Cardiac / Cardiovascular46%
Allergic / Anaphylactic46%
Gastrointestinal46%
Respiratory23%

Where reports came from

U.S. state of the reporter, where given (top 7).

StateReports
New York9
North Carolina6
Pennsylvania4
Maryland1
Massachusetts1
Tennessee1
Virginia1

Reports by month received

MonthReportsBar
2013-085
2013-095
2013-106
2013-112
2014-011
2014-031
2014-061
2014-071
2015-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Seqirus / CSL Flu lots (A–Z): P50508 · P58306 · P59107 · R53107 · R54607 · R55208

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.